Twenty-two members of the Chicago International Trade Commissioner’s Association (CITCA), focused on opportunities and partnerships in the life sciences sector, were in the Twin Cities on Sept. 17-18, hosted by the Minnesota Trade Office.
CITCA comprises trade representatives from foreign governments that are based in Chicago. CITCA members representing Austria, Belgium, Canada, China, Czech Republic, Ecuador, Flanders, France, Lithuania, Macedonia, Mexico and South Africa participated in the Minnesota biosciences tour.
“The biosciences tour is one way we are strategically identifying market demand for our state’s high quality products and services,” said MTO Executive Director Kathleen Motzenbecker, who briefed the delegation. “We are pleased to host the CITCA delegates and want them to get to know more about Minnesota’s global market presence and our biosciences capabilities, in particular.”
Minnesota is a national leader in life sciences ranking consistently in the top key life science indicators.
“We are extremely proud of our state’s bioscience backbone: Internationally renowned University of Minnesota, which you will have an opportunity to visit, and Mayo Clinic’s new Destination Medical Center,” Gov. Mark Dayton said in a letter to the CITCA delegates. “For international and domestic companies considering locations to startup, expand or relocate, Minnesota and the Twin Cities metropolitan area offer a highly educated and skilled workforce; excellent state and local support; and ideal business climate.”
Other briefings were given by the University of Minnesota’s Minnesota Medical Device Center, Visible Heart Lab and University Enterprise Laboratory and Life Science Alley.
The CITCA delegates also visited Medtronic headquarters and several smaller biosciences businesses including:
Metro Mold & Design, Rogers – Metro Mold offers services from cnc machining to custom plastic injection molding for customer markets that include surgical instruments and medical devices ;
Ximedica, St. Paul — Ximedica helps medical device and healthcare companies to develop new products from research to final manufacturing;
Prism Clinical Research, St. Paul – Prism Clinical Research is an industry leader in early phase clinical research;
Aria CV, St. Paul – Aria CV inc. is a recent startup focused on developing a therapeutic technology licensed from the University of Minnesota for the treatment of hypertension;
EmboMedics, St. Paul — The mission of EmboMedics is to develop and commercialize resorbable, and drug loaded embolization devices for the treatment of multiple indications;
Exosome Diagnostics, St. Paul — Exosome Diagnostics develops biofluid-based molecular diagnostic tests for use in personalized medicine;
Ativa Medical Corp., St. Paul — Ativa, a startup, developed a ‘micro lab’ for diagnostic testing. The company’s technology makes it easier for health providers to run tests on patients’ blood.
The Minnesota Trade Office, an office within DEED, offers programs and services to help Minnesota companies compete globally. The Trade Office provides export information, market research, education and training, and one-on-one counseling to Minnesota companies that want to sell manufactured goods and services in the international marketplace. The office also arranges and coordinates trade missions and encourages foreign companies to invest in operations in Minnesota.